Skip to primary navigation Skip to main content
0 item $0.00

Molecular Proteomics

Using quantitative proteomics to study the molecular function of secreted factors and extracellular vesicles in cancer, cardiometabolic disease and normal physiology

Read more

Laboratory head

i Profile of author

Latest Achievements

Ludwig Institute for Cancer Research Excellence Medal

International Protein Society Hans Neurath Outstanding Promise Award

ROYAN International Research Award on Reproductive Biomedicine

Inaugural LIMS Stone Protein Chemistry Fellowship

Read full biography
Dr David Greening Laboratory Head
We develop and apply quantitative proteomics to study the molecular function of secreted factors and extracellular vesicles, and quantitative proteome analysis of the dynamics associated with cancer, cardiometabolic disease, and normal physiology.


About the Molecular Proteomics laboratory

The Molecular Proteomics laboratory develops and applies quantitative proteomic techniques to study the molecular function of secreted factors and extracellular vesicles, and quantitative analysis of dynamic protein changes of normal physiology and disease-perturbed signalling networks associated with cancer and cardiometabolic disease.

Extracellular vesicles are sophisticated signalling mediators, transporting select RNA and protein cargo. As secreted vesicles they have the capacity to enable intercellular communication and have become the focus of exponentially growing interest, both to study their functions and to understand ways to use them in the development of minimally invasive diagnostics. Importantly, extracellular vesicles are released into biological fluids including blood, urine, uterine fluid, and protect their cargo against degradation and denaturation in the extracellular environment.

With various sub-types of secreted vesicles, including exosomes, are comprised of a lipid bilayer containing various proteins, RNAs and bio-active lipids. They act as intercellular messengers that give the ability to communicate between both cells of the same type and other cell types in distant organs. They are released by healthy cells, both constitutively and upon cell activation and play an important role in immune system function. Exosomes are essential for healthy physiological conditions, however under pathological circumstances, they act to potentiate cellular stress and damage. We aim to gain a better understanding on the definitive molecular mechanisms of function of extracellular vesicles, as well as investigating their capacity to target and reprogram the extracellular milieu (or in recipient cell). The advanced-nano approaches developed in our lab have identified novel regulators of secretome and extracellular vesicle biology and have utilised this knowledge for commercial and translational potential.

The Molecular Proteomics laboratory has utilised quantitative high-resolution mass spectrometry (Q Exactive HF-X Orbitrap) to deliver a superior combination of acquisition speed, resolving power, mass accuracy, spectral quality, and sensitivity. Our pipeline is focused on the rapid identification using chemical labelling and isotopic labelling strategies, in addition to label-free quantitation. We focus on utilising this technology to understanding the secreted and extracellular vesicles molecular drivers of intercellular communication and metabolism, and also defining proteome changes and key pathways involved in tissue health during cardiovascular disease.

Why proteomics?


Our expertise

We are experts in the use of mass spectrometry to give insights into active components in cells and their vesicles (cell parcels). We utilise a unique technology to identify what is present in the cell/vesicle and then map the what, where, how, why (tissues, cells, particles).

Cell diagram

Purification and characterisation of secretome and extracellular vesicle

  • Biofluids (blood), cell models, animal models.

Quantitative proteomics

  • High-resolution mass spectrometry, chemical labelling and discovery = molecular leads of function.

Translational potential

  • Designing extracellular vesicle based therapeutics.
  • Translational potential (liquid biopsy).
  • Nanoparticle delivery.

Support us

With the rising number of Australians affected by diabetes, heart disease and stroke, the need for research is more critical than ever.

Find out more